Analyst upgrades: PFE, DELL DGX and SCGLY
Posted Feb 29th 2008 11:28AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Dell (DELL), Pfizer (PFE)
.gif)
MOST NOTEWORTHY: Pfizer, Dell, Quest Diagnostics, and Societe Generale were today's noteworthy upgrades:
- Lehman upgraded Pfizer (NYSE: PFE) to Equal Weight from Underweight on valuation.
- Friedman Billings raised Dell (NASDAQ: DELL) to Outperform from Market Perform, citing expectations for improved margins next quarter, and valuation.
- Quest Diagnostics (NYSE: DGX) was upgraded to Outperform from Neutral by Credit Suisse, which cited valuation.
- Lehman upgraded shares of Societe Generale (OTC: SCGLY) to Overweight from Underweight to reflect a potential takeover by BNP Paribas and limited downside.
OTHER UPGRADES:
Tags: analyst, bayer, bayry, dell, deutsche telekom, DeutscheTelekom, dgx, dt, entergy, etr, pfe, pfizer, psa, public storage, PublicStorage, quest, scgly, societe generale, SocieteGenerale, upgrade
Nuclear power is on the comeback trail
Apple backs AT&T in continuing spat with Verizon
Closing Bell: The recession is still over, still... do you feel it?
